Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Clinical Colorectal Cancer|June 5, 2012
Multiplexed protein signal pathway mapping identifies patients with rectal cancer that responds to neoadjuvant treatmentEnzo Mammano, Francesca Galdi, Mariaelena Pierobon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2013
Hepatocyte growth factor sensitizes brain tumors to c-MET kinase inhibitionYing Zhang, Kaitlyn E Farenholtz, Yanzhi Yang, et al.
Cancer Biology & Therapy|October 25, 2023
Antibody dependent cell-mediated cytotoxicity selection pressure induces diverse mechanisms of resistanceDavid J Zahavi, Rossin Erbe, Yong-Wei Zhang, et al.
Urologic Oncology|December 3, 2014
Novel neoadjuvant therapy paradigms for bladder cancer: results from the National Cancer Center Institute ForumColin P N Dinney, Donna Hansel, David McConkey, et al.
IEEE/ACM Transactions on Computational Biology and Bioinformatics|March 10, 2015
Integration of Network Biology and Imaging to Study Cancer Phenotypes and ResponsesYe Tian, Sean S Wang, Zhen Zhang, et al.
JID Innovations : Skin Science From Molecules to Population Health|February 8, 2024
Inhibition of UV-Induced Stress Signaling and Inflammatory Responses in SKH-1 Mouse Skin by Topical Small-Molecule PD-L1 BlockadeSally E Dickinson, Prajakta Vaishampayan, Jana Jandova, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2003
Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarraysSatoshi Nishizuka, Lu Charboneau, Lynn Young, et al.
Journal of Cellular Physiology|December 20, 2018
Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuitJessika Bertacchini, Laura Mediani, Francesca Beretti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2021
Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti-PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast CancerPaula I Gonzalez-Ericsson, Julia D Wulfkhule, Rosa I Gallagher, et al.
Proteomics|October 15, 2014
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapyMaria Isabella Sereni, Elisa Baldelli, Guido Gambara, et al.
Pageof 9